Berthiaume N - Search Results

1

Metabolic responses with endothelin antagonism in a model of insulin resistance.

Berthiaume N, Wessale JL, Opgenorth TJ, Zinker BA. Berthiaume N, et al. Metabolism. 2005 Jun;54(6):735-40. doi: 10.1016/j.metabol.2004.12.019. Metabolism. 2005. PMID: 15931607

2

Metabolic responses in a model of insulin resistance: comparison between oral glucose and meal tolerance tests.

Berthiaume N, Zinker BA. Berthiaume N, et al. Metabolism. 2002 May;51(5):595-8. doi: 10.1053/meta.2002.31989. Metabolism. 2002. PMID: 11979391

3

Development of insulin resistance and endothelin-1 levels in the Zucker fatty rat.

Berthiaume N, Mika AK, Zinker BA. Berthiaume N, et al. Metabolism. 2003 Jul;52(7):845-9. doi: 10.1016/s0026-0495(03)00098-2. Metabolism. 2003. PMID: 12870159

4

Endothelin antagonism improves hepatic insulin sensitivity associated with insulin signaling in Zucker fatty rats.

Berthiaume N, Carlson CJ, Rondinone CM, Zinker BA. Berthiaume N, et al. Metabolism. 2005 Nov;54(11):1515-23. doi: 10.1016/j.metabol.2005.05.019. Metabolism. 2005. PMID: 16253642

5

Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.

Mustad VA, Demichele S, Huang YS, Mika A, Lubbers N, Berthiaume N, Polakowski J, Zinker B. Mustad VA, et al. Among authors: berthiaume n. Metabolism. 2006 Oct;55(10):1365-74. doi: 10.1016/j.metabol.2006.06.007. Metabolism. 2006. PMID: 16979408

6

The hemodynamic and metabolic profiles of Zucker diabetic fatty rats treated with a single molecule triple vasopeptidase inhibitor, CGS 35601.

Daull P, Blouin A, Beaudoin M, Gadbois S, Belleville K, Cayer J, Berthiaume N, Sirois P, Nantel F, Jeng AY, Battistini B. Daull P, et al. Among authors: berthiaume n. Exp Biol Med (Maywood). 2006 Jun;231(6):824-9. Exp Biol Med (Maywood). 2006. PMID: 16741006

7

Contribution of endogenous endothelin-1 and endothelin-A-receptors to the hypertensive state of endothelin-B heterozygous (+/-) knockout mice.

Berthiaume N, Yanagisawa M, D'Orléans-Juste P. Berthiaume N, et al. J Cardiovasc Pharmacol. 2000 Nov;36(5 Suppl 1):S72-4. J Cardiovasc Pharmacol. 2000. PMID: 11078340

8

Integrated in vivo pharmacology using an instrumented, unrestrained and conscious rat platform: application to rat models of diabetes.

Nantel F, Daull P, Berthiaume N, Duta DN, Blouin A, Cayer J, Beaudoin M, Belleville K, Benrezzak O, Sirois P, Battistini B. Nantel F, et al. Among authors: berthiaume n. J Pharmacol Toxicol Methods. 2006 May-Jun;53(3):248-55. doi: 10.1016/j.vascn.2005.09.005. Epub 2005 Nov 8. J Pharmacol Toxicol Methods. 2006. PMID: 16280249

9

Profile of past and current clinical trials involving endothelin receptor antagonists: the novel "-sentan" class of drug.

Battistini B, Berthiaume N, Kelland NF, Webb DJ, Kohan DE. Battistini B, et al. Among authors: berthiaume n. Exp Biol Med (Maywood). 2006 Jun;231(6):653-95. Exp Biol Med (Maywood). 2006. PMID: 16740981 Review.

10

The kinin system mediates hyperalgesia through the inducible bradykinin B1 receptor subtype: evidence in various experimental animal models of type 1 and type 2 diabetic neuropathy.

Gabra BH, Berthiaume N, Sirois P, Nantel F, Battistini B. Gabra BH, et al. Among authors: berthiaume n. Biol Chem. 2006 Feb;387(2):127-43. doi: 10.1515/BC.2006.018. Biol Chem. 2006. PMID: 16497144 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters